Delphic aims to provide a full suite of HIV diagnostics, from simple viral load testing through to advanced genetic tests, to pharmaceutical organisations and clinicians. Some of Delphic's tests are and have been developed internally. As part of MMC's investment, the University of Liverpool's Therapeutic Drug Monitoring service, was "˜spun in' to the business.

Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.

Founded in 2004, PinPointe USA, Inc. is a privately held, emerging medical technology with headquarters in Chico, California.

Truvian focuses on the development of automated benchtop blood testing analyzers. The company provides a compact, fully automated system that delivers results for a suite of routine blood tests from a single drop of blood. Truvian's technology aims to provide health insights during patient appointments. It was founded in 2015 and is based in San Diego, California.

Owlstone Medical focuses on breath analysis for disease detection within the healthcare sector. The company develops technology for discovering and validating biomarkers in breath, employing chemical analysis and sensor technology for diagnosis. Owlstone Medical's products and services are intended for academic, clinical, and pharmaceutical research partners involved in developing breath-based diagnostics. It was founded in 2004 and is based in Cambridge, United Kingdom.

CirculoGene Diagnostics operates within the healthcare sector, focusing on cancer detection and monitoring. The company provides genomic profiling of solid tumors at various stages, utilizing techniques like next-generation sequencing and polymerase chain reaction to analyze circulating free DNA and RNA. CirculoGene Diagnostics serves the healthcare and oncology sectors, offering products for the personalization and monitoring of cancer treatment plans. CirculoGene Diagnostics was formerly known as CirculoGene Theranostics, LLC. It was founded in 2015 and is based in Birmingham, Alabama.